SCHEMBL3010040

SCHEMBL3010040

CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
LAP3 P28838 3/20 0.50
MEN1 O00255 1/20 0.50
LMNA P02545 1/20 0.50
KMT2A Q03164 1/20 0.50
MAPT P10636 1/20 0.47
FOLH1 Q04609 2/20 0.45
MME P08473 4/20 0.44
PLA2G2A P14555 2/20 0.44
PLA2G5 P39877 2/20 0.44
LTA4H P09960 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3402343 1.00 ALDH1A1 (0.53) ALDH1A1LAP3MEN1LMNAKMT2A
SCHEMBL3010038 1.00 ALDH1A1 (0.53) ALDH1A1LAP3MEN1LMNAKMT2A
SCHEMBL29563014 1.00 ALDH1A1 (0.53) ALDH1A1LAP3MEN1LMNAKMT2A
SCHEMBL18766260 1.00 ALDH1A1 (0.53) ALDH1A1LAP3MEN1LMNAKMT2A
SCHEMBL28092554 0.98 ALDH1A1 (0.51) ALDH1A1LAP3MEN1LMNAKMT2A
SCHEMBL28092553 0.98 ALDH1A1 (0.51) ALDH1A1LAP3MEN1LMNAKMT2A
SCHEMBL16698433 0.97 ALDH1A1 (0.50) ALDH1A1LAP3MEN1LMNAKMT2A
SCHEMBL16698435 0.97 ALDH1A1 (0.50) ALDH1A1LAP3MEN1LMNAKMT2A
SCHEMBL29358488 0.94 ALDH1A1 (0.47) ALDH1A1LAP3MEN1LMNAKMT2A
SCHEMBL31027119 0.93 MME (0.48) ALDH1A1LAP3MEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4659591-A1 TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT House Foods Group Inc. (JP) 2025-12-10 EP claimed
EP-4659592-A1 FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT House Foods Corporation (JP) 2025-12-10 EP claimed
US-12285037-B2 Flavor composition and edible compositions containing same MARS, INCORPORATED (US) 2025-04-29 US claimed
CN-118759175-B Immunoglobulin G4 subtype detection kit and preparation method thereof 浙江伊利康生物技术有限公司 2025-03-21 CN claimed
WO-2024162422-A1 TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT ハウス食品グループ本社株式会社 2024-08-08 WO claimed
WO-2024162421-A1 FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT ハウス食品株式会社 2024-08-08 WO claimed
CN-116847882-A HIV vaccine and methods of use thereof 吉利德科学公司 2023-10-03 CN claimed
EP-4238981-A1 PEPTIDES WITH PLANT PROTECTION ACTION Università degli Studi di Padova (IT) 2023-09-06 EP claimed
CN-115651067-A Cyclo-C-Val-isoleu-leucin with hepatotoxicity and alpha-glucosidase inhibition activity and preparation method thereof 安徽农业大学 2023-01-31 CN claimed
EP-4053144-A2 PEPTIDES WITH PLANT PROTECTION ACTION Università degli Studi di Padova (IT) 2022-09-07 EP claimed
US-20180275144-A1 DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE PHARNEXT (FR) 2018-09-27 US claimed
WO-2016124574-A1 DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE PHARNEXT (FR) 2016-08-11 WO claimed
US-20150132440-A1 DIPEPTIDE AND TRIPEPTIDE COMPOSITIONS AND USES JHO INTELLECTUAL PROPERTY HOLDINGS, LLC 2015-05-14 US claimed
CN-103163269-B Method for fast identifying fermented soy sauce and blended soy sauce FOSHAN HAITIAN FLAVORING & FOOD CO LTD 2014-12-17 CN claimed
CN-103163248-B Method for identifying blended soy sauce FOSHAN HAITIAN FLAVORING & FOOD CO LTD 2014-05-28 CN claimed
CN-103163269-A Method for fast identifying fermented soy sauce and blended soy sauce FOSHAN HAITIAN FLAVORING & FOOD CO LTD 2013-06-19 CN claimed
CN-103163248-A Method for identifying blended soy sauce FOSHAN HAITIAN FLAVORING & FOOD CO LTD 2013-06-19 CN claimed
US-12622984-B2 High purity copper radiopharmaceutical compositions and diagnostic and therapeutic uses thereof NUCLIDIUM AG (CH) 2026-05-12 US disclosed
US-5036052-A Containing a dipeptide of tryptophan and alanine or lecine and no stabilizer; discoloration inhibition MORISHITA PHARMACEUTICAL CO., LTD. (JP) 1991-07-30 US disclosed
EP-0347890-A1 Amino acid nutrient compositions Roussel Morishita Co., Ltd. (JP) 1989-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12622984-B2 High purity copper radiopharmaceutical compositions and diagnostic and therapeutic uses thereof SSTR2, SSTR1, SSTR3 ALDH1A1 1333/4885LAP3 1865/4885MEN1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.